Norfloxacin base (70458-96-7)
Nkọwa ngwaahịa
Enwere ike iji Norfloxacin base maka ọrịa urinary tract, gonorrhea, prostatitis, ọrịa enteral, typhus na ọrịa Salmonella, ihe niile na-akpata site na anụ ahụ nwere mmetụta.
| Aha ngwaahịa | Norfloxacin |
| Ụdị okwu | 1,4-dihydro-1-ethyl-6-fluoro-4-oxo-7- (1-piperazinyl) -3-quinolinecarboxylica; ethyl-6-fluoro-1,4-dihydro-4-oxo-7- (1-piperazinyl) -3-quinolinecarboxylica; am-715;MK-366;NORFLOXACINE;NORFLOXACIN LACTATE;NORFLOXACIN;noroxin |
| CAS | 70458-96-7 |
| MF | C16H18FN3O3 |
| MW | 319.33 |
| EINECS | 274-614-4 |
| Ụdị ngwaahịa | Pharmaceutical; Ngwa ọgwụ na-arụ ọrụ; API; Intermediates & Fine Chemicals; Pharmaceuticals; API's; Aromatics; Heterocycles; Ndị na-ahụ maka ọgwụ; NOROXIN |
Enwere ike iji Norfloxacin maka ọrịa urinary tract, gonorrhea, prostatitis, ọrịa enteral, typhus na ọrịa Salmonella, ihe niile na-akpata site na anụ ahụ nwere mmetụta.
| Nnwale | Nkọwapụta | Nsonaazụ | |
| Nkọwa | Ọcha na-acha odo odo,hydroscpion, photosensitive, crystalline ntụ ntụ | Na-akwado | |
| Ihe ndị emetụtara | adịghị ọcha E | kacha.0.1% | 0.01% |
| Methyl-Norfloxacin | kacha.0.15% | 0.08% | |
| Ihe adịghị ọcha na-akọwapụtaghị | kacha.0.1% | 0.04% | |
| Mgbakọta adịghị ọcha | kacha.0.5% | 0.2% | |
| Ọnwụ na ihicha | kacha.1.0% | 0.3% | |
| Ihe fọdụrụ na mgbanye | kacha.0.1% | 0.05% | |
| Ọla dị arọ | max.15ppm | 10ppm | |
| Nyocha | 99.0% -101.0% | 99.8% | |
ngwaahịa ndị metụtara ya
Dee ozi gị ebe a ziga anyị ya
